Literature DB >> 2210702

Why patients smoke.

S M Glynn, S Sussman.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2210702     DOI： 10.1176/ps.41.9.1027

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN： 0022-1597


× No keyword cloud information.
  11 in total

1.  P50 sensory gating and attentional performance.

Authors:  Li Wan; Bruce H Friedman; Nash N Boutros; Helen J Crawford
Journal:  Int J Psychophysiol       Date:  2007-11-01       Impact factor: 2.997

2.  A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.

Authors:  Mahtab Karkhane Yousefi; Timothy D Folsom; S Hossein Fatemi
Journal:  J Addict Res Ther       Date:  2011-12-20

Review 3.  Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.

Authors:  Christie D Fowler; Michael A Arends; Paul J Kenny
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

4.  Smoking, Genetics and Schizophrenia: Evidence for Self Medication.

Authors:  Sherry Leonard; Sharon Mexal; Robert Freedman
Journal:  J Dual Diagn       Date:  2007-11-01

5.  Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.

Authors:  Athina Markou; Paul J Kenny
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 6.  Personality, psychopathology, and nicotine response as mediators of the genetics of smoking.

Authors:  D G Gilbert; B O Gilbert
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

7.  Smoking topography and outcome expectancies among individuals with schizotypy.

Authors:  Diana W Stewart; Christine Vinci; Claire E Adams; Alex S Cohen; Amy L Copeland
Journal:  Psychiatry Res       Date:  2012-12-20       Impact factor: 3.222

8.  Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia.

Authors:  Sophocles Voineskos; Vincenzo De Luca; Albert Mensah; John B Vincent; Natalia Potapova; James L Kennedy
Journal:  J Psychiatry Neurosci       Date:  2007-11       Impact factor: 6.186

9.  Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.

Authors:  Valentina Echeverria Moran
Journal:  Front Pharmacol       Date:  2012-10-10       Impact factor: 5.810

Review 10.  Lifestyle medicine for depression.

Authors:  Jerome Sarris; Adrienne O'Neil; Carolyn E Coulson; Isaac Schweitzer; Michael Berk
Journal:  BMC Psychiatry       Date:  2014-04-10       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.